The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Coronary Vasomotor Abnormalities in Insulin-Resistant Individuals
Abstract
BACKGROUND: Insulin resistance is a metabolic spectrum that progresses from hyperinsulinemia to the metabolic syndrome, impaired glucose tolerance, and finally type 2 diabetes mellitus. It is unclear when vascular abnormalities begin in this spectrum of metabolic effects. OBJECTIVE: To evaluate the association of insulin resistance with the presence and reversibility of coronary vasomotor abnormalities in young adults at low cardiovascular risk. DESIGN: Cross-sectional study followed by prospective, open-label treatment study. SETTING: University hospital. PATIENTS: 50 insulin-resistant and 22 insulin-sensitive, age-matched Mexican-American participants without glucose intolerance or traditional risk factors for or evidence of coronary artery disease. INTERVENTION: 3 months of thiazolidinedione therapy for 25 insulin-resistant patients. MEASUREMENTS: Glucose infusion rate in response to insulin infusion was used to define insulin resistance (glucose infusion rate < or = 4.00 mg/kg of body weight per minute [range, 0.90 to 3.96 mg/kg per minute]) and insulin sensitivity (glucose infusion rate > or = 7.50 mg/kg per minute [range, 7.52 to 13.92 mg/kg per minute]). Myocardial blood flow was measured by using positron emission tomography at rest, during cold pressor test (largely endothelium-dependent), and after dipyridamole administration (largely vascular smooth muscle-dependent). RESULTS: Myocardial blood flow responses to dipyridamole were similar in the insulin-sensitive and insulin-resistant groups. However, myocardial blood flow response to cold pressor test increased by 47.6% from resting values in insulin-sensitive patients and by 14.4% in insulin-resistant patients. During thiazolidinedione therapy in a subgroup of insulin-resistant patients, insulin sensitivity improved, fasting plasma insulin levels decreased, and myocardial blood flow responses to cold pressor test normalized. LIMITATIONS: The study was not randomized, and it included only 1 ethnic group. CONCLUSIONS: Insulin-resistant patients who do not have hypercholesterolemia or hypertension and do not smoke manifest coronary vasomotor abnormalities. Insulin-sensitizing thiazolidinedione therapy normalized these abnormalities. These results suggest an association between insulin resistance and abnormal coronary vasomotor function, a relationship that requires confirmation in larger studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687 · cited 2×
“Type 2 diabetes mellitus is reported to be associated with increased resting myocardial blood flow (3, 4, 21, 22), and, in 1 study, a slightly increased myocardial blood flow at baseline was associated with a paradoxical flow decrease in response to cold pressor test (22).”
BackgroundGlucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139 · cited 1×
“In contrast, although insulin resistance is a consequence of an impaired insulin receptor substrate-1/phosphatidylinositol-3-kinase/ Akt pathway, the mitogen-activated protein kinase pathway remains almost unaffected in insulin resistance (35, 36).”
BackgroundZeng, G., Nystrom, F. H., Ravichandran, L. V., Cong, L.-N., Kirby, M., Mostowski, H., & Quon, M. J. (2000) · Circulation · doi:10.1161/01.cir.101.13.1539 · Cited by 745
Zeng, G., & Quon, M. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118871 · Cited by 726 · cited 1×
“Defective insulin receptor substrate-1/phosphatidylinositol-3-kinase/Akt insulin signaling not only interferes with glucose metabolism but also blunts insulin-mediated increase in nitric oxide (34).”
BackgroundInsulin Causes Endothelial Dysfunction in Humans: Sites and Mechanisms
Arcaro, G., Cretti, A., Balzano, S., Lechi, A., Muggeo, M., Bonora, E., & Bonadonna, R. C. (2002) · Circulation · doi:10.1161/hc0502.103333 · Cited by 407
Krook, A., Björnholm, M., Galuska, D., Jiang, X. J., Fahlman, R., Myers, M. G., Wallberg-Henriksson, H., & Zierath, J. R. (2000) · Diabetes · doi:10.2337/diabetes.49.2.284 · Cited by 375 · cited 1×
“In contrast, although insulin resistance is a consequence of an impaired insulin receptor substrate-1/phosphatidylinositol-3-kinase/ Akt pathway, the mitogen-activated protein kinase pathway remains almost unaffected in insulin resistance (35, 36).”
BackgroundEffects of cardiac sympathetic innervation on coronary blood flow
Di Carli, M. F., Tobes, M. C., Mangner, T., Levine, A. B., Muzik, O., Chakroborty, P., & Levine, T. B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361703 · Cited by 237
Cited by
Coronary Microvascular Dysfunction
Crea, F., Lanza, G. A., & Camici, P. G. (2014) · Springer eBooks · doi:10.1007/978-88-470-5367-0 · Cited by 1,287
Murthy, V. L., Naya, M., Foster, C. R., Gaber, M., Hainer, J., Klein, J., Dorbala, S., Blankstein, R., & Di Carli, M. F. (2012) · Circulation · doi:10.1161/circulationaha.112.120402 · Cited by 549
Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases
Cersosimo, E., & DeFronzo, R. A. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.634 · Cited by 525
Coronary microvascular dysfunction: mechanisms and functional assessment
Camici, P. G., d'Amati, G., & Rimoldi, O. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.160 · Cited by 498
Schindler, T. H., Schelbert, H. R., Quercioli, A., & Dilsizian, V. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2010.04.007 · Cited by 424
Self-citation
Metadata
- Authors
- Quiñones, M. J., Hernandez-Pampaloni, M., Schelbert, H., Bulnes-Enriquez, I., Jimenez, X., Hernandez, G., De La Rosa, R., Chon, Y., Yang, H., Nicholas, S. B., Modilevsky, T., Yu, K., Van Herle, K., Castellani, L. W., Elashoff, R., & Hsueh, W. A.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2004-05-04
- Volume
- 140
- Issue
- 9
- Pages
- 700-708
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2108081459
- Cited by
- 163
- References
- 10
- FWCI
- 10.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Coronary Vasomotor Abnormalities in Insulin-Resistant Individuals. https://app.cochat.ai/papers/10.7326/0003-4819-140-9-200405040-00009
- The paper
- Quiñones, M. J., Hernandez-Pampaloni, M., Schelbert, H., Bulnes-Enriquez, I., Jimenez, X., Hernandez, G., De La Rosa, R., Chon, Y., Yang, H., Nicholas, S. B., Modilevsky, T., Yu, K., Van Herle, K., Castellani, L. W., Elashoff, R., & Hsueh, W. A. (2004). Coronary Vasomotor Abnormalities in Insulin-Resistant Individuals. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-140-9-200405040-00009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.